Catalogs from Slingshot Biosciences
Precision-Engineered Synthetic Cell Mimics
Slingshot Biosciences develops precision-engineered synthetic cell mimics designed to deliver consistent, reproducible control materials for flow cytometry and related applications. Unlike donor-derived controls, Slingshot’s solutions are free from donor variability and biological drift, helping improve assay consistency while reducing bridging studies and supporting harmonization across sites. The portfolio covers a broad range of applications, including immunophenotyping, instrument setup and harmonization. Slingshot controls are non-biohazardous, stable, reproducible, and available off-the-shelf or as fully customizable solutions – making them a practical choice for routine QC, assay validation, optimization, and long-term performance monitoring. Released September 2026.
TruCytes™ as a Reliable Alternative to PBMC Controls – App Note
Flow cytometry-based immunophenotyping relies on consistent controls to accurately identify immune cell subsets. Traditional donor-derived PBMC controls can suffer from donor variability, lot-to-lot inconsistencies, limited stability, and complex sourcing. Slingshot Biosciences’ TruCytes™ Lymphocyte Subsets Controls provide a scalable, reproducible alternative. These engineered cell mimics replicate key optical and biochemical properties of T cells, B cells, NK cells, and monocytes, with precisely controlled scatter and biomarker expression. The application note demonstrates their lot-to-lot consistency, reproducibility, extended stability, and compatibility with standard immunophenotyping workflows. Released September 2026.